The global pharmaceutical excipients market is expanding steadily as pharmaceutical companies continue to develop more advanced drug formulations and delivery systems. Pharmaceutical excipients are inactive substances used in combination with active pharmaceutical ingredients (APIs) to ensure drug stability, improve bioavailability, and support the manufacturing process. These ingredients play a vital role in enhancing the effectiveness, safety, and shelf life of pharmaceutical products.

According to market insights, the global pharmaceutical excipients market was valued at US$ 7,825.38 million in 2021 and is projected to reach US$ 12,245.04 million by 2028, registering a compound annual growth rate (CAGR) of 6.6% during the forecast period from 2022 to 2028. The market growth is driven by the rising demand for generic drugs, increased pharmaceutical production, and the growing adoption of advanced drug delivery technologies.

Download Sample PDF Report:
https://www.theinsightpartners.com/sample/TIPRE00003534

Market Overview

Pharmaceutical excipients are essential components used in various drug formulations such as tablets, capsules, liquids, injectables, and topical medications. They serve several functions, including improving the physical characteristics of drugs, enhancing drug absorption, and supporting the stability of active ingredients.

As pharmaceutical companies continue to innovate and develop complex therapies, the demand for specialized excipients has increased significantly. The pharmaceutical excipients market is also benefiting from ongoing research and development activities aimed at improving formulation technologies and ensuring compliance with regulatory standards.

A key aspect of understanding the pharmaceutical excipients market is analyzing its segmentation across multiple categories such as type, clinical indication, application, and end user. These segments help identify the major demand areas and growth opportunities within the market.

Pharmaceutical Excipients Market Segmentation Analysis

By Type

Based on type, the pharmaceutical excipients market is segmented into bioresorbable polymers, lipids, oleochemicals, sugars, cellulose, starches, petrochemicals, plant proteins, polyols and cyclodextrins, inorganic chemicals, and others.

Among these segments, cellulose and starch-based excipients hold a significant share due to their widespread use in tablet and capsule formulations. Cellulose derivatives are commonly used as binders, fillers, and disintegrants, making them essential in solid oral dosage forms.

Sugars such as lactose are also widely used as fillers and stabilizers in pharmaceutical formulations. Additionally, polyols and cyclodextrins are gaining increasing attention for their ability to improve drug solubility and enhance bioavailability in complex drug formulations.

By Clinical Indication

Based on clinical indication, the market is categorized into cancer, metabolic diseases, infectious diseases, ophthalmic diseases, dental diseases, gene therapies, and others.

The cancer segment represents a significant share due to the rising prevalence of oncology-related conditions and increasing development of targeted cancer therapies. Many cancer drugs require specialized excipients to ensure stability and effective drug delivery.

Metabolic diseases such as diabetes and obesity are also contributing to the growth of this segment, as long-term medication often requires optimized drug formulations supported by high-quality excipients.

By Application

Based on application, the pharmaceutical excipients market is segmented into oral formulations, capsules, liquid injectables, topical formulations, nutraceuticals and OTC drugs, and prefilled syringe interactions.

The oral formulations segment dominates the market, as tablets and capsules remain the most widely used dosage forms globally. Oral dosage forms are preferred due to their ease of administration, cost-effectiveness, and convenience for patients.

Liquid injectables are also witnessing increased demand due to the growing use of biologic drugs and vaccines. These formulations require specialized excipients to maintain stability and ensure proper delivery of sensitive active ingredients.

Topical formulations and nutraceutical applications are also expanding as consumers increasingly focus on preventive healthcare and self-medication.

By End User

Based on end users, the market is segmented into pharmaceutical companies, biopharmaceutical companies, and animal health manufacturers.

Pharmaceutical companies account for a major share of the market due to their extensive involvement in drug development and manufacturing. These companies rely heavily on excipients to ensure the quality, stability, and effectiveness of their pharmaceutical products.

Biopharmaceutical companies are also emerging as a significant segment due to the growing development of biologics and biosimilars. These therapies often require advanced excipient technologies to protect sensitive molecules and maintain product integrity.

Animal health manufacturers represent another important segment as veterinary medicines increasingly adopt advanced formulations similar to those used in human pharmaceuticals.

Regional Market Insights

Geographically, the pharmaceutical excipients market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South & Central America.

North America holds a leading position in the market due to strong pharmaceutical manufacturing infrastructure, advanced research capabilities, and the presence of major pharmaceutical companies.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Countries such as India and China have emerged as major pharmaceutical manufacturing hubs, supported by cost advantages, expanding healthcare sectors, and increasing investments in pharmaceutical research and development.

Key Market Players

Prominent companies operating in the global pharmaceutical excipients market include:

·         BASF SE

·         Evonik Industries AG

·         Roquette Frères SA

·         Ashland Inc.

·         Archer-Daniels-Midland Company

·         The Dow Chemical Company

·         The Lubrizol Corporation

·         Avantor Inc.

·         MEGGLE GmbH & Co. KG

·         JRS Pharma GmbH & Co. KG

·         Univar Solutions Inc.

These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market position and meet the increasing demand for advanced excipient solutions.

Future Market Outlook

The pharmaceutical excipients market is expected to witness steady growth through 2028 as pharmaceutical companies continue to develop innovative drug formulations and advanced therapies. Increasing demand for generic drugs, rising biopharmaceutical development, and technological advancements in excipient manufacturing will continue to support market expansion.

As drug formulations become more complex and targeted, the demand for specialized excipients across different therapeutic areas and applications is expected to increase, creating significant growth opportunities for industry participants.

Related Reports:

Plant Based Vaccines Market

Travel Vaccines Market

Unresectable Hepatocellular Carcinoma Market

About Us

The Insight Partners is a leading global market research and consulting firm specializing in delivering actionable insights across various industries. Our research reports combine extensive primary and secondary research to provide accurate market intelligence, helping businesses make informed strategic decisions. The company provides detailed analysis on emerging technologies, market trends, competitive landscapes, and growth opportunities across sectors including technology, healthcare, manufacturing, and energy.

Contact Us

The Insight Partners
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

Also Available in : Korean |German |Japanese |French |Chinese |Italian |Spanish